Sr One Capital Management, LPFirm match from fund name (lower confidence)
SR One Capital Fund III, LP
Open: first sale Oct 2024, per Form D (fund age approximates vintage)
- Vintage
- 2024
- Fund size
- $247.33M to $600M (Form D)
- Stages
- Not stated
- Sectors
- Biotech
- Regions
- US, Global
01 · Thesis
SR One is a biotechnology venture capital firm that partners with founders and entrepreneurs to translate innovative science into medicines. It takes a back-and-build approach, focusing on companies with strong fundamentals, a clearly defined development pathway, and novel approaches to disease.Inferred from the firm's website
02 · Initial check
$2.47M to $10M (estimated from fund size)
Estimated from Form D: $247.33M sold of a $600M target
03 · Who to approach
Named on this fund's Form D
- Rajeev Dadoo
- Simeon George
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideA biotechnology venture capital firm, partnering with founders and entrepreneurs to translate innovative science into medicines.
A biotechnology venture capital firm, partnering with founders and entrepreneurs to translate innovative science into medicines.
https://www.srone.com/
06 · Sources
Last verified: Oct 28, 2026